Mice homozygous for the c 14c°s albino deletion die as neonates as a result of liver dysfunction. Previous mapping studies have associated this defect with a 310-kb fragment encoding the hepatocyte-specific developmental regulation locus (alf/hsdr-1). The gene encoding fumarylacetoacetate hydrolase (Fah), a metabolic enzyme that catalyzes the last step of tyrosine catabolism, also maps to the same deletion interval. To test whether the neonatal defects found in the albino deletion mutants are attributable to loss of Fah, and not to another gene mapping to the deletion, we have generated Fah mutant mice by gene targeting in embryonic stem cells. Fah-deficient mice die within 12 hr after birth from hypoglycemia and liver dysfunction. In addition, the same pattern of altered liver mRNA expression found in the albino deletion mutants was also found in affected animals. We conclude that the neonatal lethal and liver dysfunction phenotype of the alf/hsdr-1 deletion is entirely attributable to loss of Fah.
The c 14c°s albino mouse is one of a series of mutant mice bearing large overlapping X-ray-induced deletions of chromosome 7 (Russell et al. 1979 ). The albino deletions contain several loci involved in development and are all estimated to be several megabases in size. Mice homozygous for various albino deletions have different phenotypes ranging from developmental arrest in utero to neonatal death as a result of liver dysfunction. Mice homozygous for the deletions C 65Kb, C ll2Kb, C 3H, and c 14c°s die within a few hours after birth and display abnormal or no expression of many hepatic enzymes (GluecksohnWaelsch 1979; Russell et al. 1979; Rinchik and Russell 1990) . These include tyrosine aminotransferase (TAT) (Schmid et al. 1985) , glucose-6 phosphatase (G-6P) (Gluecksohn-Waelsch 1979) , glutamine synthetase (GS) (Gluecksohn-Waelsch 1979) , phosphoenolpyruvate carboxykinase (PEPCK) (Loose et al. 1986 ), aldolase B, albumin, ~-fetoprotein (Sala-Trepat et al. 1985) , urea cycle enzymes (Gluecksohn-Waelsch et al. 1974; Sala-Trepat et al. 1985; Schmid et al. 1985; Loose et al. 1986; Morris et al. 1988) , several liver transcription factors (McKnight et al. 1989; Gonzalez et al. 1990; Ruppert et al. 1990;  SCorresponding author. T6njes et al. 1992) , and two anonymous transcripts Xl and X2 (Ruppert et al. 1990 ). Reduced expression is associated with lower mRNA levels for TAT, PEPCK, the urea cycle genes, and aldolase B, but normal steady-state mRNA levels are found for the serum proteins (SalaTrepat et al. 1985) . Electron microscopy examination reveals structural abnormalities in both liver and kidney of these mice (Gluecksohn-Waelsch 1979) . Many of the enzymes affected play a role in glucose homeostasis, suggesting hypoglycemia as the cause of death in the newbom mice (Gluecksohn-Waelsch 1979) . Several, although not all, of the genes involved are normally inducible by glucocorticoids and/or cAMP, but this does not occur in the albino deletion mice (Schmid et al. 1985) . This observation has led to the hypothesis that a regulatory liver gene [hepatocyte-specific developmental regulation locus (hsdr-1)] is localized within the deletion (McKnight et al. 1989) . This locus has also been termed Detailed mapping of the deletion interval in the c 14c°s mice has identified a 310-kb fragment within which the alf/hsdr-1 gene must be localized (Niswander et al. 1991; Kelsey et al. 1992) . Recently, two groups reported the isolation of a liver-specific eDNA from the 310-kb deletion interval encoding fumarylacetoacetate (FAA) hydrolase (Fah, EC 3.7.1.2) Ruppert et al. 1992) . Fah catalyzes the last step in tyrosine catabolism, the conversion of FAA to acetoacetate and fumarate (see Fig. 1 ) (Knox and Edwards 1955; Goldsmith and Laberge 1989) . In addition, the timing and localization of Fah expression in the mouse fits the pattern predicted for alf/hsdr-1 , and some of the phenotypic abnormalities seen in the alf/hsdr-1 deletion can be reproduced in primary liver cells stressed with homogentisic acid ). These observations suggest, but do not prove, that Fah is identical to alf/ hsdr-1.
In humans, deficiency of FAA hydrolase causes hereditary tyrosinemia type I (HT1), a severe, autosomal recessive inborn error of metabolism (Lindblad et al. 1977; Tanguay et al. 1984} . Affected children develop liver failure in the first few months after birth and frequently die within a year (Kvittingen 1986; Goldsmith and Laberge 
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HOOC "CH 2-~H 2-C "CH 2-C "CH 3 Figure 1 . Tyrosine degradation pathway. The principal metabolites in the pathway are tyrosine (Tyr), p-OH-phenylpyruvate (PHPP), homogentisic acid (HGA), maleylacetoacetate (MAA), fumarylacetoacetate (FAA), succinylacetoacetate (SAA), and succinylacetone (SA). The enzymes are TAT (1), p-OH-phenylpyruvate dioxygenase (2), homogentisic acid oxidase (3), MAA isomerase (4), and FAA hydrolase (5). The broken lines indicate metabolic steps, in which the exact enzymes/mechanisms involved are not known.
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1989). Additional features of the disorder include renal tubular dysfunction, cardiomyopathy (Edwards et al. 1987) , and severe neurologic crisis (Mitchell et al. 1990 ). Hepatomas and, in later stages, hepatocellular carcinomas are a very frequent complication (Russo and O'Regan 1990) . Biochemically, the disease is characterized by the accumulation of multiple abnormal compounds in blood and urine: tyrosine, methionine, tyrosine metabolites, and succinylacetone (SA) (Goldsmith and Laberge 1989) . SA is the diagnostic metabolite in Fah deficiency in humans and is not found in urine of healthy individuals. It presumably derives from the reduction of maleylacetoacetate (MAA) and FAA in vivo (see Fig. 1 ). It has been speculated, but not proven, that MAA and FAA are primarily responsible for much of the local tissue damage leading to necrosis of hepatocytes and other cells (Lindblad et al. 1977; Goldsmith and Laberge 1989) . Several remarkable secondary biochemical alterations have been described in human HT1, including the inhibition of 8-aminolevulinic acid dehydratase by SA Kappas 1982, 1983) , elevations in serum ~-fetoprotein levels, and decreased levels of several hepatic enzymes, especially TAT. Evidence for depletion of intracellular reducing compounds, such as low levels of glutathione in red cells and a deficit in cysteine, has been found (Stoner et al. 1984) .
Here, we report the derivation of mice deficient in Fah by use of targeted gene disruption in embryonic stem (ES) cells to determine the relationship between the alf/ hsdr-1 locus and this metabolic enzyme. Possible explanations for the observed phenotype and the differences between murine and human Fah deficiency are discussed.
Results

Derivation of Fah-mice
The Fah gene was disrupted with a replacement vector (pD10), in which a neo expression cassette was inserted into a unique SphI site in exon 5 of the gene ( Fig. 2A) .
This construct had -5 kb of homology 5' and -1.5 kb 3' to the insertion, respectively. Because exon 5 was found to be 91 bp long (data not shown), a neo insertion should lead to a frameshift and a null allele, even if the targeted exon was skipped during splicing. A herpes simplex virus thymidine kinase (HSV TK) expression cassette was included at the 3' end of the homology to select against nontargeted insertions. After linearization, the replacement vector was electroporated into ES cells and doubleselection with G418 and gancyclovir, was carried out. Doubly resistant clones [14/120 (-1/8)] analyzed by Southern blot with probe A (Fig. 2B) showed the 1.4-kb increase in size expected for a targeting event. The Southern blots were also probed with neo to verify the presence of only one copy of the replacement vector in the cells (Fig. 2B) . A third probe derived from the region 5' to the homology was used to demonstrate that the 5' flank of the disrupted locus had the expected structure (data not shown). Five targeted ES clones were injected into C57BL/6J blastocysts, and two gave rise to germ- line chimeras, from which we established the mutant strains Fah aex°nS-1 and Faha¢x°"s-2. All results discussed below were identical for both strains and independent of the genetic background (129Sv or hybrid 129Sv-C57BL/ 6j).
Fah aexo, s homozygotes die in the neonatal period
Fah a~*°~s heterozygotes were bred, and their offspring were analyzed. No obvious differences in morphology or size were noted immediately after birth, and all pups appeared vigorous and healthy at first. In most litters, however, one to three dead pups were found after 6-12 hr. Southern blot analysis of these dead animals revealed that they were all Fah a . . . . s homozygotes. Because there were no obvious morphologic parameters for the homozygotes before their death, a simple PCR-based test was developed to determine genotype (data not shown).
No Fah a~x°"s homozygotes were observed to survive past 24 hr after birth. For further analysis of the phenotype, all pups were sacrificed within 12 hr after birth, dissected, and genotyped by PCR by use of tail DNA. Among 221 pups, 70 were homozygous wild type (32%), 106 were heterozygous (48%), and 45 were Fah a~*°~s homozygous (20%). Thus, slightly fewer than the expected 25% of animals were homozygotes. This distortion could be explained by decreased intrauterine viability, but more likely is caused by missing some animals that died early postnatally and were eaten. No statistically significant weight differences were detected among the three different genotypes (Table 1) .
Homozygous Fah a . . . . s mice have multiple biochemical abnormalities
Several biochemical parameters were analyzed in the Fah aex°ns strain to compare the biochemical phenotype with that of c 14c°s albino deletion mice. First, Fah measurement in liver revealed a complete absence of enzyme activity in Fah aex°ns homozygotes. Heterozygotes had approximately half the activity (10.8+2.25 ~m o l e / m g per rain) of wild-type littermates (20.1 + 1.9 ~m o l e / m g per min). It therefore appears that the Fah acX°ns mutation represents a null allele.
Blood glucose was measured during two different time intervals: immediately after birth or >6 hr after birth. No significant differences between the three genotypes were observed immediately after birth. Homozygotes, however, had markedly decreased blood glucose levels, if they were sacrificed >6 hr postnatally (Table 1) , indicating a gradual onset of hypoglycemia during the first few hr of life. Similar decreases to less than half of normal blood glucose level have also been observed in c 14c°s deletion homozygotes (Gluecksohn-Waelsch 1979) .
Fah is primarily expressed in liver and kidney in both m a n and mouse; therefore, blood chemistries that correlate with function of these organs were of interest. Two parameters were determined. The plasma levels of the liver enzyme aspartate aminotransferase (AST), which The parameters measured and the units in -which they are expressed are at left. The values +--S.D. are given for each genotype, with the numbers in parentheses indicating the number of animals analyzed.
correlates with hepatocellular damage (leakage of this hepatic enzyme into the circulation), was measured and found to be markedly elevated in the homozygotes, with values as high as 3840 U/liter (see Table 1 ). Some homozygotes had levels within the normal range, which was likely related to the time after birth at which the blood sample was taken. Severe hepatocellular damage may be an end-stage event. The plasma creatinine levels, a measure of renal function, were also elevated in the homozygotes (Table 1) . Quantitative plasma amino acid analysis was carried out on several litters. Abnormal amino acid values are listed in Table 1 . Interestingly and in contrast to human Fah deficiency, no elevations in the plasma tyrosine levels were detected in the affected animals. Phenylalanine and methionine levels, however, were increased about threefold in homozygotes. Most significant, however, were the abnormalities in arginine, citrulline, and ornithine, amino acids that participate in the urea cycle. The elevations in citrulline and omithine were mild (only two-to threefold), but arginine was nondetectable in Fah-deficient pups. The abnormalities in urea cycle-related amino acids again are in contrast to the human HT1 phenotype, in which no such disturbances have been reported.
SA is the hallmark metabolite of human tyrosinemia and is derived directly from FAA, the substrate of Fah (see Fig. 1 ). To detect this compound, organic acids were extracted from the livers of animals and analyzed quantitatively by gas chromatography and mass spectrometry; but even with this highly sensitive method, no SA was detectable in liver extracts in Fah-deficient homozygores. This result was consistent with a previous report, in which SA levels in liver were measured in homozygous C 14C°S mice and found not to be elevated (Collins et al. 1992) . The relevance of this finding, however, was questionable, because it has been shown in human HT1 patients, that SA is often not elevated in liver, whereas it is easily detectable in plasma and urine in the same patient (Tuchman et al. 1985) . For this reason, SA analysis was also carried out in plasma. SA was clearly detectable in the plasma of zkexon5 homozygotes at a level of -0.5 ~g/ml, whereas it was undetectable in unaffected littermates. SA levels in human HT1 patients are of the same order of magnitude (0.3 -20 ~g/ml) (Grenier and Lescault 1985) .
Electron microscopy examination shows disruption of the endoplasmic reticulum
Because no consistent differences in the histological appearance of livers from homozygous deficient, heterozygous, and wild-type mice could be found by use of light microscopy, an electron microscopy study was undertaken. This revealed extensive depletion of glycogen from the cytoplasm with corresponding reduction in size of the hepatocytes (Fig. 3B) . In addition, the usual parallel arrays of rough endoplasmic reticulum found in the immature hepatocytes of wild-type mice (Fig. 3A) were disrupted in the homozygous Fah-deficient animals. The rough endoplasmic reticulum that remained was scattered widely within the cells. Some focal vesiculation of the endoplasmic reticulum was found in a few hepatocytes. These alterations are similar to those observed by Gluecksohn-Waelsch (1979) in the lethal albino mouse.
Fah mutant animals show the pattern of mRNA abnormalities seen m lethal albino mice
The deletion of the alf/hsdr-1 locus in albino mutant mice leads to characteristic alterations of the expression pattern of certain mRNAs in the livers of homozygous animals. The steady-state levels of some mRNAs, most notably those inducible by cAMP, are decreased. Other transcripts, especially some mRNAs inducible by DNA damage, are present in increased amounts. Yet another group of genes is not affected by the alf/hsclr-1 deletion.
We determined the mRNA levels of several examples of these groups by Northern blot analysis (Fig. 4) .
In all cases, the expression pattern of the Fah ae'°ns mice was identical to that reported for mice deleted at the alf/hsdr-1 locus. No detectable Fah mRNA was ob- served in homozygous Fah aex°ns mice, confirming that the neo insertion into exon 5 has created a null allele. The mRNA levels of the cAMP-inducible genes TAT, PEPCK, and the urea cycle enzymes argininosuccinate synthetase (AS) and ornithine transcarbamylase (OTC) were all markedly decreased, whereas NMO-1 and CHOP mRNA levels were increased. The mRNA levels of albumin (data not shown), al-antitrypsin (oL1-AT), a-fetoprotein (aFP, data not shown), ornithine aminotransferase, and tubulin were unaltered.
Discussion
The Fah gene is a candidate for the alf/hsdr-1 locus
The alf/hsdr-1 locus in the mouse has been the subject of intense investigation for many years. The generalized down-regulation of multiple liver-specific cAMP-responsive genes in several strains of albino deletion mice has led to the hypothesis that the deletions must contain a key regulatory locus involved in controlling the expression of these genes (Gluecksohn-Waelsch and DeFranco 1991 ). The notion of a specific regulatory defect was supported by the report that the failure of induction was limited to cAMP-responsive liver genes and was not present in genes inducible by metal ions . Over time, however, additional abnormalities were described in these mice, which were less consistent with a specific defect. Increased mRNA levels of genes inducible by DNA damage (Fornace et al. 1989 ) and those involved in detoxification pathways were found (Petersen et al. 1989 ). Decreased transcription rates were documented for genes not inducible by cAMP (T6njes et al. 1992 ) and low steady-state mRNA levels were found for several liver transcription factors (McKnight et al. 1989; Gonzalez et al. 1990; Ruppert et al. 1990; T6njes et al. 1992) .
Efforts by several groups to clone the alf/hsdr-1 gene focused on utilizing the different overlapping albino deletions to narrow down the location of the gene (Niswander et al. 1991; Kelsey et al. 1992} . In 1992, two groups successfully isolated the Fah gene from the 310-kb region of overlap between different deletions, thereby raising the question whether loss of Fah was the cause for the alf/hsdr-1 deletion phenotype Ruppert et al. 1992) . Additional experiments made a strong case for the identity of the two loci . The c 14c°s deletion was shown to disrupt the Fah gene, and Fah is expressed primarily in liver and kidney, beginning at day 16 as had been predicted for the alf/ hsdr-1 gene. In addition, primary hepatocytes cultured in the presence of homogentisic acid (HGA) displayed some of the abnormalities seen in livers of c 14c°s homozygotes. Although this evidence was supportive of the
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Loss of Fah results in the same phenotype as the alf/hsdr-1 deletion
To resolve this question, we have derived a strain of mice bearing a mutation in the Fah gene only. This mutation appears to be a null allele, as evidenced by complete absence of Fah m R N A and enzyme activity in homozygous mice. The phenotype found in Fah-deficient pups is indistinguishable from that reported for homozygous c ~4c°s mice. First, it was shown that PEPCK, TAT, OTC, and AS m R N A levels are markedly decreased in Fah-deficient pups. Second, NMO-1 and CHOP levels were markedly increased. Third, albumin, oL1-AT, and oLFP were not altered. Fourth, Fah aex°ns homozygotes suffer from hypoglycemia. Fifth, no alterations of liver histology were detectable in light microscopy, but electron microscopy showed abnormalities, particularly of the endoplasmic reticulum. And, finally, the biochemical phenotype, including serum amino and liver organic acids, was the same as that reported for c ~4c°s mice. Thus, there was complete concordance between the phenotypes in all parameters studied. It therefore appears that all significant aspects of the alf/hsdr-1 deletion phenotype can be explained by deficiency of Fah alone. The X-ray-induced deletions of classic mutant mouse strains are generally large in size and likely to contain several loci. The phenotype of homozygotes is determined by which deleted locus or loci has the most severe effect in terms of viability and age of onset. The possibility that the observed phenotype is the result of multiple interacting deletions has to be taken into consideration. The Fah-mice described here are, to our knowledge, the first example in which the targeted disruption of a single gene within the deletion has been shown to be responsible for the major component of the deletion phenotype. This approach will be useful in the analysis of other large deletion mutations containing developmental genes.
Possible mechanisms of the alf/hsdr-1 phenotype
The mechanisms, by which Fah deficiency causes the rather specific abnormalities are not clear at this point. The compounds MAA and FAA, which immediately precede the metabolic block, are known to be reactive alkylating substances (R. Tanguay, pers. comm.) . SA is in equilibrium with FAA and MAA (see Fig. 1 ) and is stable enough to accumulate and be detectable in HT1 h u m a n patients. The half-lives of MAA and FAA, on the other hand, are very short, and these compounds therefore cannot be directly detected in Fah-deficient individuals. It has been suggested that the accumulation of FAA and MAA may be responsible for the abnormalities seen in c 14c°s hepatocytes Kelsey and Schtitz 1993) . This hypothesis was questioned by a report demonstrating that SA was not elevated in the liver of c 14c°s mice (Collins et al. 1992 ). This finding implied either that FAA and MAA did not accumulate and cause the disregulation or that their conversion to SA was deficient in these mice. We have shown here that SA is present in elevated amounts in plasma of Fah-deficient mice and is of the same order of magnitude as seen in h u m a n patients. This indicates an accumulation of the toxic metabolites MAA and FAA in Fah-deficient mice and is consistent with the notion that these chemicals
cause the alf/hsdr-1 deletion phenotype. The failure to detect SA in the liver of Fah-deficient subjects is not unique to mice as it has been reported for HT1 patients as well (Tuchman et al. 1985) and might be attributable to entrapment of available SA as a result of protein binding.
At this time one can only speculate about how the toxic metabolites exert their effect. Both MAA and FAA are predicted to react with sulfhydryl groups and could possibly alter the redox potential of cells. Several transcription factors are already known to require a reduced state to be functional (Abate et al. 1990; Xanthoudakis and Curran 1992) . One can hypothesize that one or several of these transcription factors may be rendered nonfunctional by alkylation in Fah-deficient animals. Further experiments, which will assess the redox state of Fah-deficient liver cells and address the effects of reducing agents on the phenotype, will be required to resolve these questions.
The phenotypes of Fah deficiency in mice and humans are different
The phenotypes of Fah deficiency in humans and mice are rather different. The most striking difference is the short life span of affected mice. This is not explained by more mild mutations in HT1 patients. Several reports indicate that most tyrosinemic patients have null alleles (Phaneuf et al. 1992 ). In addition, Fah-deficient mice are not tyrosinemic (i.e. they do not have elevations of plasma tyrosine) and human HT1 patients do not suffer from hypoglycemia. Preliminary results in human HT1 patients (R. Tanguay, pers. comm. and M. Grompe, unpubl.) indicate that disregulation of alf/hsdr-l-dependent mRNAs is not a major factor in the pathophysiology of human tyrosinemia.
To find major differences in phenotypes between humans and mice deficient in the same gene product is hardly a new phenomenon (Wu and Melton 1993) . In the case of Fah deficiency, several possible explanations come to mind. First, the flux of metabolites through the tyrosine degradation pathway may be quantitatively very different in the two species. Thus, it is possible, that the different phenotypes are explained by higher levels of toxic metabolites in the mouse liver. Second, mouse hepatocytes may be more sensitive to MAA and FAA. Mouse cells may be more dependent on a transcription factor that is susceptible to alkylation. Alternatively, the potential to buffer the effects of alkylating compounds with reducing agents such as glutathione may be lower in newborn mice. It is theoretically also possible that Fah uses yet-unidentified substrates in the mouse and that it is the accumulation of compounds other than FAA and MAA that cause the hepatic dysfunction. Fah is known to utilize several other diketo acids in vitro (Hsiang et al. 1972) . This question will be answerable by specifically disrupting the tyrosine catabolic pathway upstream to Fah in our mice. This could be achieved either pharmacologically by inhibiting p-OH phenylpyruvate dioxygenase using NTBC (Lindstedt et al. 1992) or by breeding Fah-deficient animals with a recently described strain of mice deficient in that enzyme (Endo et al. 1991) .
Despite the differences in phenotype, the Fah-deficient mouse strain described here can be used as an improved disease model for some aspects of human HT1. Because all phenotypic effects can be clearly attributed to Fah deficiency alone, therapeutic effects of drugs and diets can be assessed more clearly in this background. This is especially important, if such interventions lead to a prolonged survival, because the effects of deficiencies of other genes in the deletion may then be seen.
Materials and methods
Construction of the replacement vector
A KDASH II/129 mouse genomic library was screened with the full-length mouse Fah eDNA (Grompe and A1-Dhalimy 1992) . Phages mFah 6 and 15 containing the 5' end of the gene were characterized further by restriction mapping and probing with partial eDNA probes. A map of mFah phage 15 is shown in figure 2A . A 6.5-kb EcoRV-NotI fragment from the 3' end of mFah 15 was cloned into pBluescript, and a unique SphI site was found to be located 5 kb from the 5' and 1.5 kb from the 3' end. DNA sequencing confirmed that this SphI site was located within a 91-bp exon and corresponded to the unique SphI site found in the eDNA. A neo expression cassette, pol2Sneo (Softano et al. 1991) , was inserted into this site, and an HSV TK expression cassette (PGKTK) (Soriano et al. 1991 ) was cloned into the SacII site at the 3' end of the homology, creating the replacement vector pD10 (Fig. 2) .
Generation of mice with a targeted mutation in the Fah gene
Culture and electroporation of AB1 ES cells were as described previously (Soriano et al 1991) . DNA was prepared from individual clones, digested with HindIII and Southern blotted (Ramffez-Solis et al. 1992) using probe A (see Fig. 2 ). Blastocyst injections were as described previously (Bradley 1987) .
PCR genotyping
Three PCR primers were designed. Primers A and B were located 5' and 3' to exon 5 of the Fah gene, respectively. Primer C was located at the 3' end of the pol2Sneo expression cassette within the bovine growth hormone polyadenylation sequence. For genotyping, PCR (Mullis and Faloona 1987) was carried out with all three primers simultaneously on 200 ng of tail-cut DNA (Miller et al. 1988 ). The wild-type fragment produced by use of primers A and B was 180 bp, and the mutant fragment with primers C and B was 240 bp. Primer sequences were A, 5'-CTAGGTCAATGGCTGTTTGG-3'; B, 5'-GGACATACCA-ATTTGGCAAC-3'; and C, 5'-TAAAATGAGGAAATTGCAT-CG-3'. The amplification conditions were 94°C for 5 rain, followed by 31 cycles of 90°C for 30 sec, 56°C for 30 sec, and 72°C for 50 sec in a previously described buffer (Kogan et al. 1987) .
Histology and electron microscopy
Electron microscopy was performed on tissues fixed in buffered formalin. The samples were then postosmicated, embedded in araldite, sectioned on an AO-Reichert ultracut E microtome, and stained with uranyl acetate and lead citrate. Sections were examined in a Joel 100-CX microscope at magnifications ranging from 800 to 12,000x.
Biochemical analysis
Samples from animals were obtained as follows. The pups were sacrificed by decapitation, and blood was collected by dabbing the wound onto Parafilm. For anticoagulation, the blood was mixed immediately with 1 ~1 of 500 mM EDTA using a Pipetman. The red blood cells were removed by a brief centrifugation, and the plasma was frozen at -80°C until PCR genotyping was completed. Next, the liver was removed and also frozen at -80°C.
Fah enzyme assay
Fah enzyme assays were carried out at 30°C on a cytosolic fraction of homogenized liver as described previously by Knox (Knox and Edwards 1955) . FAA, the substrate for the assay, is not commercially available and was prepared from homogentisic acid as described in the same reference. Protein concentrations were measured with a Bio-Rad kit {Bradford 1976).
Blood glucose measurements
Plasma glucose concentrations were determined by a coupled hexokinase/G-6P dehydrogenase assay {Bondar and Mead 1974) with commercially available reagents {Sigma).
AST and creatinine measurements
Twenty microliters of plasma was mixed with 80 ~1 of a solution of 7% bovine serum albumin and assayed for AST and creatinine levels with a Kodak Ektachem 700 chemistry analyzer.
Quantitative amino acid analysis
Individual plasma samples of 25 jzl were quantitated on a Beckman 6300 automated amino acid analyzer (Sturman and Applegarth 1985) .
Organic acid analysis
Mouse liver (20-50 mg) was homogenized in 0.8 ml of methanol and centrifuged at 12,000g for 5 rain. The supernatant was removed and diluted to 5 ml with HPLC grade water. Pooled plasma samples (100 ~1) were diluted with 4.5 ml of water and then treated identically to the liver samples. The diluted samples were oximated for 1 hr with 100 mg of hydroxylamine hydrochloride at room temperature and at pH > 12. The mixture was then acidified with HC1 to pH 1, poured onto a liquid/ liquid extraction column (Varian Chem Elut CE 1005), and extracted with ethylacetate. The extracts were dried under nitrogen and derivatized with 25 ~1 of N, O-bis(trimethisilyl) trifluoroacetamide + 1% trimethylchlorosilane {Pierce) at 85°C for 20 min. The sample was loaded onto a Hewlett-Packard 5890 GC/5970 mass spectroscopy instrument operating in the selected ion monitoring mode. The ions monitored were of masses 110, 138, 182, 212, and 227 for the two closely eluting methyl isoxazole propionate derivatives of oximated SA (Tuchman et al. 1984) . A control sample was prepared in parallel but was spiked with 0.12 ~g of SA at the beginning of the procedure. The detection limit for SA in liver homogenate was 1 ng/mg wet, weight and for plasma it was 0.1 ~g/ml.
Northern blots
Total cellular RNA was isolated from frozen liver by the RNAzol method (Chomczynski and Sacchi 1987) . Poly(A) RNA was prepared using a Polytract System III kit (Promega). Ten micrograms (total cellular RNA) or 250 ng (poly{A) RNA) of RNA was electrophoresed through a formaldehyde gel (Sambrook et al. 1989 ) and transferred onto Hybond N + membrane (Amersham). Equal amounts of either total cellular RNA or poly(A) RNA were loaded into each lane. The equal loading was confirmed by reprobing each of the blots with tubulin. Hybridization was at 42°C in 6x SSPE, 5x Denhardt's solution, 0.5% SDS, and 50% formamide. The probes used are described in the following references: Fah {Grompe and A1-Dhalimy 1992); murine PEPCK (Lem et al. 1988) ; TAT (Lem et al. 1988) ; AS (Surh et al. 1991) ; OTC (Veres et al. 1987) ; NMO-1 (Ruppert et al. 1990 ); al-AT (Sifers et al. 1990 ); OAT {kindly provided by D. Valle, Johns Hopkins University, Baltimore, MD); and albumin (Lem et al. 1988) ; and tubulin (Lem et al. 1988) . The routine CHOP (Ron and Habener 1992) and human aFP probes were generated by PCR based on published sequences.
